Global Vitamin D testing market is expected to grow with an impressive growth rate in the next five years on the account of rise in the geriatric population along with the increase in the chronic diseases like diabetes Type 2, kidney diseases, Crohn’s disease, and celiac disease, the increasing number of infections and autoimmune diseases, a growing number of strategic developments by vendors and innovative product offerings by vendors. The chronic diseases are rapidly growing at an alarming rate and need to find the drug that can overcome the disease and acts as a treatment further.
Vitamin D is an essential nutrient that plays a crucial role in maintaining bone health and regulating the immune system. A deficiency of Vitamin D can lead to various health problems such as osteoporosis, rickets, and an increased risk of certain types of cancer. As a result, there has been a growing emphasis on the need for Vitamin D testing to detect and monitor Vitamin D deficiency in individuals.
Furthermore, the ongoing research and development, clinical trials, approval and commercialization of new clinical tests, geographical expansions and governmental support toward the research and development, are expected to boost the market growth of global Vitamin D testing market during the next five years.
Increasing incidence of Vitamin D deficiency
As per the data of National Center for Biotechnology Information (NCBI), National Institute of Health 2022, Vitamin D deficiency is a global public health issue in which around 1 billion people worldwide have Vitamin D deficiency, while 50% of the population has Vitamin D insufficiency
Rising Prevalence of Chronic Diseases
Several chronic diseases, such as osteoporosis, cardiovascular disease, and diabetes, have been linked to Vitamin D deficiency. As the global prevalence of these diseases continues to rise, there is a growing demand for Vitamin D testing to identify individuals at risk and to guide treatment strategies. The critical roles of Vitamin D in several endocrine, paracrine, and autocrine activities have been specified in various studies. Vitamin D deficiency in adults acts as a key factor for the development of various communicable and non-communicable diseases. For instance, inadequate levels of Vitamin D play a major role for the development of diseases like colon cancer, breast cancer, cardiovascular diseases, diabetes mellitus, multiple sclerosis, rheumatoid arthritis, Parkinson’s disease, tuberculosis etc. Despite the high physiological importance, deficiency of this vitamin is commonly reported around the world. According to the reports, approximately 1 billion people worldwide are affected with vitamin-D deficiency and around 50% of the global population have Vitamin D insufficiency. Additionally, the prevalence of Vitamin D deficiency in Europe, USA and Middle East has been reported to range from 20% to 90%.
Several factors have been highlighted as underlying variables to explain this world-wide variation of Vitamin D status among different populations. Degree of sunlight exposure and the factors that influence its duration and intensity ultimately influence the level of Vitamin D amongst population.
For instance, in April 2020, according to an article published by WebMD LLC, it was reported that the global prevalence of IBD is 396 cases per 100,000 persons annually. Also, the patients are suffering from Vitamin D deficiency is seeking medical attention for the treatment of Vitamin D deficiency and rising in a economic burden. Eventually, this led to increase initiatives for awareness campaigns regarding the importance of Vitamin D by the government and other for profit and non-profit organizations.
Recent developments & Product Launches
n November 2020, Omega Quant launched a Vitamin D test with a sample collection kit, allowing normal levels to be tested at home. The method was safe, simple, and convenient test requires just a finger stick and a couple drops of blood for analysis in the range of omega-3 blood tests. Secondly in March 2020, Thermo Fisher Scientific announced the availability of the Cascadion SM clinical analyzer for the Cascadion SM 25-Hydroxy Vitamin D assay in the United States
In 2021, a nutrition firm namely Royal DSM launched a digital campaign in India with the aim of raising awareness among the people for routine check-ups of Vitamin D levels in the body. Hence, shows an impressive growth of the Global Vitamin D Testing Market.
Increasing Adoption of Point-Of-Care Testing
According to the National Institutes of Health (NIH), more than one billion people worldwide are estimated to have vitamin D deficiency, which can lead to a range of health problems, including weakened bones, muscle weakness, and an increased risk of certain cancers.
Market Segmentation
Global Vitamin D Testing Market can be segmented based on by product, by indication, by end user, and by region. Based on product, the market can be categorized into 25-Hydroxy Vitamin D Testing, 1,25-Dihydroxy Vitamin D Testing, 24,25-Dihydroxy Vitamin D Testing. Based on indication, the market can be fragmented into Osteoporosis, Rickets, Thyroid Disorders, Malabsorption, Vitamin D Deficiency, and others. Based on end user, the market can be grouped into diagnostic laboratories, hospitals and clinics, homecare settings, and others.
Company Profiles
Hoffmann-La Roche Ltd., Abbott Laboratories Ltd., Siemens Corporation Ltd., Danaher Corporation Ltd., Quest Diagnostics, Inc., BioMerieux SA, DiaSorin S.p.A., Thermo Fisher Scientific Inc., Quidel Corporation Ltd., Beckman Coulter Inc., Biokit S.A., Tosoh Bioscience, Inc., Qualigen Inc., Diazyme Laboratories, Inc., Hologic, Inc., etc. are some of the key players operating in the global Vitamin D testing market.
Attribute | Details |
Base Year | 2022 |
Historical Years | 2018 – 2022 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million and CAGR for 2018-2022 and 2023-2028 |
Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered | · Product · Indication · End User · Region · Company |
Regional Scope | North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa |
Country Scope | United States; Canada; Mexico; China; India; Japan; South Korea; Australia; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; Saudi Arabia; UAE; South Africa |
Key Companies Profiled | F. Hoffmann-La Roche Ltd., Abbott Laboratories Ltd., Siemens Corporation Ltd., Danaher Corporation Ltd., Quest Diagnostics, Inc., BioMérieux SA, DiaSorin S.p.A., Thermo Fisher Scientific Inc., Quidel Corporation Ltd., Beckman Coulter Inc., Biokit S.A., Tosoh Bioscience, Inc., Qualigen Inc., Diazyme Laboratories, Inc., Hologic, Inc. |
Customization Scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |